Literature DB >> 19720773

Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

William L Lanier.   

Abstract

Mesh:

Year:  2009        PMID: 19720773      PMCID: PMC2735425          DOI: 10.1016/S0025-6196(11)60485-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  74 in total

1.  Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8.

Authors:  Gregory D Curfman; Stephen Morrissey; Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

2.  Publication of market-driven research in medical journals.

Authors:  Stuart Holtby; Pamela Wakewich
Journal:  Mayo Clin Proc       Date:  2006-06       Impact factor: 7.616

3.  How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag".

Authors:  David Armstrong
Journal:  Wall St J (East Ed)       Date:  2006-05-15

4.  Editor's note: Industry support of articles published in Mayo Clinic Proceedings.

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2006-06       Impact factor: 7.616

5.  Ghost marketing: pharmaceutical companies and ghostwritten journal articles.

Authors:  Barton Moffatt; Carl Elliott
Journal:  Perspect Biol Med       Date:  2007       Impact factor: 1.416

6.  Clinical trial registration: looking back and moving ahead.

Authors:  Christine Laine; Richard Horton; Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Fiona Godlee; Charlotte Haug; Paul C Hébert; Sheldon Kotzin; Ana Marusic; Peush Sahni; Torben V Schroeder; Harold C Sox; Martin B Van Der Weyden; Freek W A Verheugt
Journal:  Med J Aust       Date:  2007-06-18       Impact factor: 7.738

7.  Clinical trial registration: looking back and moving ahead.

Authors:  Christine Laine; Richard Horton; Catherine D DeAngelis; Jeffrey M Drazen; Frank A Frizelle; Fiona Godlee; Charlotte Haug; Paul C Hébert; Sheldon Kotzin; Ana Marusić; Peush Sahni; Torben V Schroeder; Harold C Sox; Martin B Van Der Weyden; Freek W A Verheugt
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

8.  Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.

Authors:  Catherine D De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Harold C Sox; Martin B Van Der Weyden
Journal:  Haematologica       Date:  2006-03       Impact factor: 9.941

9.  Clinical trial registration: looking back and moving ahead.

Authors:  Christine Laine; Richard Horton; Catherine D DeAngelis; Jeffrey M Drazen; Frank A Frizelle; Fiona Godlee; Charlotte Haug; Paul C Hébert; Sheldon Kotzin; Ana Marusic; Peush Sahni; Torben V Schroeder; Harold C Sox; Martin B Van der Weyden; Freek W A Verheugt
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

10.  Managing conflict of interest in clinical practice.

Authors:  Michael Camilleri; Denis A Cortese
Journal:  Mayo Clin Proc       Date:  2007-05       Impact factor: 7.616

View more
  8 in total

1.  Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.

Authors:  F Alfonso; A Timmis; F J Pinto; G Ambrosio; H Ector; P Kulakowski; P Vardas
Journal:  Neth Heart J       Date:  2012-06       Impact factor: 2.380

2.  Professional medical organizations and commercial conflicts of interest: ethical issues.

Authors:  Howard Brody
Journal:  Ann Fam Med       Date:  2010 Jul-Aug       Impact factor: 5.166

3.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

Authors:  Joseph S Ross; Harlan M Krumholz
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

4.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

Authors:  Jeffrey R Garber
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

5.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

Authors:  Allan Rowan Kelly
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

6.  Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

Authors:  Rafael Fonseca; Paul Richardson; Sergio Giralt; Sagar Lonial; S Vincent Rajkumar; A Keith Stewart; William Bensinger; George Somlo; Robert Vescio; Joseph Mikhael; Craig Reeder; Rodger Tiedemann; Guido Tricot; Robert Rifkin; John Shaughnessy; Nikhil Munshi; Noopur Raje; Irene Ghobrial; Jacob Laubach; Robert Schlossman; Steven Treon; Anuj Mahindra; David Avigan; Jacalyn Rosenblatt; Sundar Jagannath; Ruben Niesvizky; Heather Landau; Selina Chen-Kiang; David S Siegel; Todd Zimmerman; Jayesh Mehta; David Vesole; Steven Rosen; Craig Hofmeister; Martha Lacy; Angela Dispenzieri; Ivan Borrello; Suzanne R Hayman; Shaji Kumar; Frances Buadi; David Dingli; Stephen Russell; Melissa Alsina Melissa Alsina; Hugo Fernandez; Vivek Roy; Denise Pereira; Edward Stadtmauer; Ravi Vij; Andrzej Jakubowiak; Suzanne Lentzsch; Kevin Song; Suzanne Trudel; Christine Chen; Donna Reece; Douglas Stewart; Seema Singhal; Raymond Comenzo; Morie A Gertz; Philip R Greipp; Brian Durie; Bart Barlogie; Kenneth Anderson; William Dalton; Morton Coleman; Susie Novis; Robert A Kyle
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

7.  Myelodysplastic syndromes--many new drugs, little therapeutic progress.

Authors:  Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2010-09-22       Impact factor: 7.616

8.  Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.

Authors:  Bernadette A Mansi; Juli Clark; Frank S David; Thomas M Gesell; Susan Glasser; John Gonzalez; Daniel G Haller; Christine Laine; Charles L Miller; LaVerne A Mooney; Maja Zecevic
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.